Stock listing

OTC:BPMUF Basilea Pharmaceutica AG Stock

US listing (OTC) of Basilea Pharmaceutica AG · home listing SIX Swiss:BSLN

Follow Basilea Pharmaceutica AG into a list and get an email when it puts out news.

Share price · OTC:BPMUF

$76.25 USD 0.00 (0.0%)

Close on Oct 16, 2026

Day range
$76.25 – $76.25 USDOct 16, 2026
Market value
$944.9M USDAt the close on Oct 16, 2026 · price × 12.39M shares outstanding
Basilea Pharmaceutica AG logo
Ticker
OTC:BPMUF
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call

    Tue, Aug 18, 2026 · 10:00 AM ET

    Watch Transcript

Latest news

Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients

Sep 14, 2026

Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track

Aug 18, 2026

Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Aug 5, 2026

Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix

Jul 29, 2026

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

May 28, 2026

Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting

Apr 15, 2026

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

Apr 9, 2026

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

Mar 23, 2026

Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Feb 25, 2026

Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance

Feb 17, 2026

All Basilea Pharmaceutica AG news

Decks

Basilea Pharmaceutica AG on 6ix

News releases
18 in the last 12 months · 30 in all · newest Sep 14, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Aug 18, 2026
Decks
4 decks · latest Oct 1, 2026

Where Basilea Pharmaceutica AG is listed

ListingExchangeCountryCurrency
SIX Swiss:BSLN · Home listingSIX SwissSwitzerlandCHF
LSE:0QNALSEUnited KingdomCHF
gettex:PK5gettexGermanyEUR
Aquis:BSLNZAquisUnited KingdomCHF
OTC:BPMUF · This pageOTCUnited StatesUSD
Lang & Schwarz:A0B9GALang & SchwarzGermanyEUR
LS Exchange:A0B9GALS ExchangeGermanyEUR
Tradegate:PK5TradegateGermanyEUR
BX Swiss:PK5BX SwissSwitzerlandCHF
Munich:PK5MunichGermanyEUR
Turquoise:BSLNZTurquoiseUnited KingdomCHF
Dusseldorf:PK5DusseldorfGermanyEUR
Frankfurt:PK5FrankfurtGermanyEUR
Hamburg:PK5HamburgGermanyEUR
Stuttgart:PK5StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Basilea Pharmaceutica AG.